Skip Navigation

European Heart Journal 2001 22(24):2224-2226; doi:10.1053/euhj.2001.2833
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Laffan, M.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laffan, M.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Fibrinogen polymorphisms and disease

M.A. Laffan

Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, U.K.

References

  1. Blake, GJ, Schmitz, C, Lindpaintner, K, Ridker, PM, Mutation in the promoter region of the ß-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J, 2001, 22, 2262, 6
  2. Meade TW, Mellows S, Brozovic M. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533–537[Web of Science][Medline]
  3. Tybjaerg Hansen A, Agerholm Larsen B, Humphries SE. A common mutation (G-455->A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest. 1997;99:3034–3039[Web of Science][Medline]
  4. Tracy RP, Arnold AM, Ettinger W. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol. 1999;19:1776–1783[Abstract/Free Full Text]
  5. Humphries SE, Ye S, Talmud P. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol. 1995;15:96–104[Abstract/Free Full Text]
  6. Sweetnam PM, Yarnell JW, Lowe GD. The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies. Br J Haematol. 1998;100:582–588[CrossRef][Web of Science][Medline]
  7. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo J. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635–641[Abstract/Free Full Text]
  8. Koster T, Rosendaal FR, Reitsma PH. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms—the Leiden Thrombophilia Study (LETS). Thromb Haemost. 1994;71:719–722[Web of Science][Medline]
  9. Tracy RP. Epidemiological evidence for inflammation in cardiovascular disease. Thromb Haemost. 1999;82:826–831[Web of Science][Medline]
  10. Bini, A, Fenoglio, JJ, Jr. Mesa Tejada, R, Kudryk, B, Kaplan, KL, Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis, Use of monoclonal antibodies, Arteriosclerosis, 1989, 9, 109, 21
  11. Xiao Q, Danton MJ, Witte DP. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice. J Clin Invest. 1998;101:1184–1194[Web of Science][Medline]
  12. Yee KO, Schwartz SM. Why atherosclerotic vessels narrow: the fibrin hypothesis. Thromb Haemost. 1999;82:762–771[Web of Science][Medline]
  13. Behar S. Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention. Blood Coagul Fibrinolysis. 1999;10:S41–43
  14. Behague I, Poirier O, Nicaud V. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation. 1996;93:440–449[Abstract/Free Full Text]
  15. van 't Hooft FM, von Bahr SJ, Silveira A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol. 1999;19:3063–3070[Abstract/Free Full Text]
  16. Doggen CJ, Kunz G, Rosendaal FR. A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men. Thromb Haemost. 1998;80:743–748[Web of Science][Medline]
  17. Humphries SE, Green FR, Temple A. Genetic factors determining thrombosis and fibrinolysis. Ann Epidemiol. 1992;2:371–385[Medline]
  18. Gardemann A, Schwartz O, Haberbosch W. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thromb Haemost. 1997;77:1120–1126[Web of Science][Medline]
  19. Wang XL, Wang J, McCredie RM, Wilcken DE. Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17:246–251[Abstract/Free Full Text]
  20. de Maat MP, Kastelein JJ, Jukema JW. –455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol. 1998;18:265–271[Abstract/Free Full Text]
  21. Zito F, Di Castelnuovo A, Amore C. Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients. Arterioscler Thromb Vasc Biol. 1997;17:3489–3494[Abstract/Free Full Text]
  22. Ma J, Hennekens CH, Ridker PM, Stampfer MJ. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol. 1999;33:1347–1352[Abstract/Free Full Text]
  23. Fishman D, Faulds G, Jeffery R. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–1376[Web of Science][Medline]
  24. Lane D, Grant P. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000;95:1517–1532[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Laffan, M.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laffan, M.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?